Latest Breaking News On - Vichrow biotech - Page 2 : comparemela.com

Bharat Biotech to raise Covaxin s production to 12 million a month by July

Bharat Biotech to raise Covaxin s production to 12 million a month by July
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshStelis biopharmaCentral drug laboratorySerum institute of indiaRussian direct investment fundHyderabad based bharat biotechHetero biopharmaGland pharmaVichrow biotechஆந்திரா பிரதேஷ்மைய மருந்து ஆய்வகம்சீரம் நிறுவனம் ஆஃப் இந்தியாரஷ்ய நேரடி முதலீடு நிதிஹைதராபாத் அடிப்படையிலானது பாரத் பயோடெக்சுரப்பி பார்மா

India gets third Covid-19 vaccine, how it may boost fight against coronavirus pandemic

India gets third Covid-19 vaccine, how it may boost fight against coronavirus pandemic
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Madhya pradeshUnited statesAndhra pradeshUttar pradeshKirill dmitrievZydus cadilaStelis biopharmaGamaleya research instituteSerum institute of indiaRussian direct investment fundSerum instituteBharat biotechBoth covishieldHetero biopharmaGland pharmaVichrow biotech

India likely to have 5 more Covid vaccines by October; nod to Russia s Sputnik soon: Sources | India News

India News: India is likely to have five more Covid vaccines by October this year as the Centre is planning to scale up vaccinations amid a rapid surge in cases.

Andhra pradeshJohnson bioZydus cadilaCadilla zydusStelis biopharmaSerum institute covishieldRussian direct investment fundSerum indiaBharat biotechIntranasal vaccineDirect investment fundHetero biopharmaGland pharmaVichrow biotechNasal vaccineSerum institute

India to have 5 more vaccines by Oct, Sputnik nod likely in 10 days: Report

India to have 5 more vaccines by Oct, Sputnik nod likely in 10 days: Report
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshJohnson bioZydus cadilaCadilla zydusStelis biopharmaRussian direct investment fundSerum indiaBharat biotechDirect investment fundHetero biopharmaGland pharmaVichrow biotechNasal vaccineCentral governmentஆந்திரா பிரதேஷ்ஜான்சன் உயிர்

Five COVID-19 vaccines likely by end of Q3; Sputnik V, Novavax, J&J in line

Five COVID-19 vaccines likely by end of Q3; Sputnik V, Novavax, J&J in line Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy s Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V BusinessToday.In | April 11, 2021 | Updated 16:16 IST More COVID-19 vaccines in pipeline By the end of the third quarter, India is likely to get vaccines from five additional manufacturers, including Sputnik V, Novavax and Johnson & Johnson s vaccines. This comes amid reports of shortage of COVID-19 vaccine doses from multiple states. The central government is aiming to scale up vaccine production. So far, India has two vaccines manufactured locally Covishield and Covaxin.

Zydus cadilaStelis biopharmaRussian direct investment fundSerum indiaBharat biotechDirect investment fundHetero biopharmaGland pharmaVichrow biotechCentral governmentCovid 19 vaccination in indiaVaccination for covid 19Covid 19 vaccinationCovid 19 vaccination programmeCovid 19 vaccineVaccination in india